Oncology News | pharmaphorum

News

Astellas expands Poseida alliance on solid tumour CAR-Ts

Astellas has clearly been impressed with a partnership signed last August with Poseida Therapeutics on the development of cell therapies for solid tumours, as it has just

News

Jacobio plans bid for China’s KRAS market with safety edge

Jacobio Pharma has reported the results of its pivotal Chinese study of KRAS G12C inhibitor glecirasib, with a safety profile that could differentiate it from other drugs

News

Ono swoops on Deciphera in $2.4 billion takeover

Japan’s Ono Pharma has bolstered its cancer pipeline with a $2.4 billion agreement to buy Deciphera Pharma of the US and its fast-growing gastrointestinal stromal tumour (

News

Merck, Huma alliance bears fruit with UK bladder cancer app

Mere months after announcing a partnership to develop digital support tools for cancer patients, Huma Therapeutics and Merck KGaA have launched their first app in the UK.

News

J&J gets CHMP nod for Rybrevant in first-line lung cancer

Johnson & Johnson’s Rybrevant is on the brink of EU approval as a treatment for a subset of patients with newly diagnosed EGFR-positive lung cancer, after a recommenda

News

Endeavor raises $132.5m for fibrosis, cancer drugs

Endeavor BioMedicines has completed a third round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi

Astellas expands Poseida alliance on solid tumour CAR-Ts

Jacobio plans bid for China’s KRAS market with safety edge

Ono swoops on Deciphera in $2.4 billion takeover

Merck, Huma alliance bears fruit with UK bladder cancer app

J&J gets CHMP nod for Rybrevant in first-line lung cancer

Endeavor raises $132.5m for fibrosis, cancer drugs

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

News

Editor's Picks